The India nicotine replacement therapy market size is expected to reach USD 75.74 million by 2030, registering a CAGR 12.56% from 2024 to 2030, according to the study. The substantially high magnitude of India's tobacco user base, regional socioeconomic disparities, and the significant financial burdens associated with tobacco use boost the nicotine replacement therapy market & its role in addressing these challenges. The growing awareness of these issues, supported by government initiatives and collaborative efforts, presents a substantial growth opportunity for NRT products in India.
The inclusion of NRT in the National List of Essential Medicines (NLEM) in September 2022 marks a significant milestone. This move is poised to enhance accessibility and affordability. However, price capping could slow down market growth. Rigorous tobacco scrutiny ads and regulations have contributed to increased awareness about the risks associated with smoking, prompting individuals to seek safer alternatives like NRT. India has a well-defined regulatory framework for pharmaceuticals and healthcare products, which can provide a clear pathway for the legal approval & distribution of NRTs. Moreover, existing tobacco control laws and regulations can create a favorable legal environment for adopting NRTs as a harm reduction strategy.
Widespread retail expansion is expected to improve the accessibility of NRT products in India. Expansion of the retail sector in India is enhancing the accessibility of NRT products. It goes beyond mere convenience, highlighting the profound impact of this expansion on affordability, awareness, and the broader effort to provide effective smoking cessation solutions to a wider range of consumers in India.
Due to the expansion, NRT products are accessible beyond urban centers, ensuring that individuals in semi-urban and rural areas can access these smoking cessation aids. In addition, it improves affordability by fostering competition among retailers, making NRT more cost-effective. Furthermore, the visible placement of NRT products in retail outlets enhances awareness and normalizes conversations about quitting smoking. The convenience of purchasing products locally or online aligns with the lifestyles of several individuals in India, reducing tobacco consumption.
Affordability has remained a persistent challenge in terms of accessibility to NRT, particularly for low-income individuals residing in rural India. This obstacle posed difficulties in effectively combating tobacco addiction among this demographic. Despite efforts to these products NRT more affordable, insurance coverage remains the leading challenge. The lack of adequate financial support continues to hinder the most vulnerable populations from accessing smoking cessation aids.
This product will be delivered within 2 business days.
The inclusion of NRT in the National List of Essential Medicines (NLEM) in September 2022 marks a significant milestone. This move is poised to enhance accessibility and affordability. However, price capping could slow down market growth. Rigorous tobacco scrutiny ads and regulations have contributed to increased awareness about the risks associated with smoking, prompting individuals to seek safer alternatives like NRT. India has a well-defined regulatory framework for pharmaceuticals and healthcare products, which can provide a clear pathway for the legal approval & distribution of NRTs. Moreover, existing tobacco control laws and regulations can create a favorable legal environment for adopting NRTs as a harm reduction strategy.
Widespread retail expansion is expected to improve the accessibility of NRT products in India. Expansion of the retail sector in India is enhancing the accessibility of NRT products. It goes beyond mere convenience, highlighting the profound impact of this expansion on affordability, awareness, and the broader effort to provide effective smoking cessation solutions to a wider range of consumers in India.
Due to the expansion, NRT products are accessible beyond urban centers, ensuring that individuals in semi-urban and rural areas can access these smoking cessation aids. In addition, it improves affordability by fostering competition among retailers, making NRT more cost-effective. Furthermore, the visible placement of NRT products in retail outlets enhances awareness and normalizes conversations about quitting smoking. The convenience of purchasing products locally or online aligns with the lifestyles of several individuals in India, reducing tobacco consumption.
Affordability has remained a persistent challenge in terms of accessibility to NRT, particularly for low-income individuals residing in rural India. This obstacle posed difficulties in effectively combating tobacco addiction among this demographic. Despite efforts to these products NRT more affordable, insurance coverage remains the leading challenge. The lack of adequate financial support continues to hinder the most vulnerable populations from accessing smoking cessation aids.
India Nicotine Replacement Therapy Market Report Highlights
- Based on product, gums dominated the market in 2023 due to increasing emphasis on NRTs and growing involvement of the government, and developments in the industry
- Based on strength, 4 mg held the largest share of the market due to higher price of 4 mg products. Higher pricing is often seen as indicative of increased potency for heavy smokers, which appeals to consumers seeking more robust solutions to address their nicotine cravings and addiction
- Based on distribution channel, the offline segment dominated the India nicotine replacement sector in 2023
- Accessibility of NRT products in retail pharmacies reflects the commitment to public health and highlights the importance of making cessation aids readily available to those looking to overcome smoking addiction
This product will be delivered within 2 business days.
Table of Contents
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 India Nicotine Replacement Therapy Market - State Analysis, 2018-2030 (USD Million)
Chapter 4 India Nicotine Replacement Therapy Market Variables, Trends, And Scope
Chapter 5 India Nicotine Replacement Therapy Market Analysis, By City, 2018-2030 (Revenue, USD Million) (Volume, Skus In Millions)
Chapter 6 India Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018-2030 (USD Million)
Chapter 7 India Nicotine Replacement Therapy Market - Segment Analysis, By Strength, 2018-2030 (USD Million)
Chapter 8 India Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018-2030 (USD Million)
Chapter 9 Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Glenmark Pharmaceuticals Ltd.
- Fertin Pharma
- Rubicon Consumer Healthcare Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Rusan Pharma Ltd.
- Cipla, Inc.
- Piramal Pharma Limited
- Itc Limited
- Inventz Lifesciences
- Sparsha Pharma International Pvt. Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 33.09 Million |
| Forecasted Market Value ( USD | $ 75.74 Million |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | India |
| No. of Companies Mentioned | 10 |
